The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.5, a high ...

Globus Medical seems to be reverting to form, reporting a big jump in operating profit and profit margin for Q1, 2025. Here ...

Medical device company Globus Medical (NYSE:GMED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company ...

Feb 9 (Reuters) - Globus Medical Inc (GMED.N), opens new tab said on Thursday it would acquire peer NuVasive Inc (NUVA.O), opens new tab in an all-stock deal valued at about $3 billion to build ...